CBMG - Cellular Biomedicine Group, Inc.
We couldn't determine Recommendation based on the data we have.

Unless specified, all values are in USD Millions. Data extracted from SEC Filing and are subject to processing and input errors.
Cellular Biomedicine Group, Inc. (CBMG) -
Cellular Biomedicine Group, Inc. is a holding company, which engages in the development of new treatments for cancerous and degenerative diseases utilizing proprietary cell-based technologies. It specializes in immune cell therapy. The company was founded in 2009 and is headquartered in New York, NY.
Exchange - NASDAQ
Industry - Biotechnology
Sector - Health Technology
CEO - Bi Zuo Liu
Employees - 217

Disclaimer - Investment in securities involves substantial risk and could result in significant loss. It is not suitable for every investor. Before acting on information on this website, you should consider whether it is suitable for your particular circumstances and strongly consider seeking advice from your own financial or investment adviser. We may own some of the securities mentioned in this website.
Know the Stock © 2021 and future.